According to its published materials, it offers compounded semaglutide injections starting at $199/month, compounded tirzepatide injections starting at $299/month, liquid drop and lozenge formulations starting at $199$289/month, and brand-name FDA-approved options such as Foundayo through a separate membership-plus-medication path
Weight-loss medications rarely qualify for expedited review unless the patient has an acute comorbidity (e.g., uncontrolled diabetes with recent hospitalization)
Inhalers GlaxoSmithKline discontinued production of their Flovent HFA inhaler and also launched an authorized generic
Researchers have found that people taking GLP-1 medications may have a higher risk of developing gastroparesis compared to people using some other weight loss medications
Critically, the study documented no significant changes in oral glucose tolerance tests, no alterations in fasting insulin levels, and no changes in serum IGF-1 concentrations across all treatment groups